Clinical trialNAActive not recruiting
A Supervised Prehabilitation Program for Patients With Pancreatic Cancer
- Outcome
- Ongoing
- Phase
- NA
- Status
- Active not recruiting
- Study type
- Interventional
- Start
- 15 May 2023
- Expected end
- 1 April 2027
- Enrollment
- 16 participants
- Sites
- 1
- Primary outcomes
- PREHAB Feasibility
- Sponsor
- Other
- Results posted
- 2026-04-15
- Last update
- 19 August 2026
These are registry fields. A trial card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess.
Try
Source text
Brief summary public domain (ClinicalTrials.gov)
The purpose of this study is to assess the use of an exercise program in people with pancreatic cancer.
Detailed description public domain (ClinicalTrials.gov)
Attendance to exercise sessions as well as impacts on healthcare utilization, muscle mass, quality of life, physical activity, and post-operative outcomes when applicable will be monitored. Study participants will participant in a supervised, in-person exercise program 3 times per week for 6 weeks. Participants will receive a Fitbit to be worn continuously during the study and complete surveys and exercise tests at specified timepoints (Baseline, Post-Intervention Evaluation and 3-Month Follow Up).
Posted results (ClinicalTrials.gov registry) · primary outcome public domain (ClinicalTrials.gov)
PREHAB Feasibility [From Baseline to 3 Months]. Count Of Participants, Participants. Supervised Prehabilitation Exercise Program (n=16): 10.
Posted results (ClinicalTrials.gov registry) · secondary outcome public domain (ClinicalTrials.gov)
PREHAB Program Safety [From Baseline to 3 Months]. Count Of Participants, Participants. Abdominal pain: Supervised Prehabilitation Exercise Program (n=16): 2. Alanine aminotransferase increased: Supervised Prehabilitation Exercise Program (n=16): 1. Alkaline phosphatase increased: Supervised Prehabilitation Exercise Program (n=16): 2. Anemia: Supervised Prehabilitation Exercise Program (n=16): 2. Aspartate aminotransferase increased: Supervised Prehabilitation Exercise Program (n=16): 1. Back pain: Supervised Prehabilitation Exercise Program (n=16): 1. Blood bilirubin increased: Supervised Prehabilitation Exercise Program (n=16): 1. Confusion: Supervised Prehabilitation Exercise Program (n=16): 1. Constipation: Supervised Prehabilitation Exercise Program (n=16): 1. Diarrhea: Supervised Prehabilitation Exercise Program (n=16): 2. Dizziness: Supervised Prehabilitation Exercise Program (n=16): 1. Dyspnea: Supervised Prehabilitation Exercise Program (n=16): 1. Fatigue: Supervised Prehabilitation Exercise Program (n=16): 6. Fever: Supervised Prehabilitation Exercise Program (n=16): 1. Headache: Supervised Prehabilitation Exercise Program (n=16): 1. Hyperglycemia: Supervised Prehabilitation Exercise Program (n=16): 1. Hypocalcemia: Supervised Prehabilitation Exercise Program (n=16): 1. Hypokalemia: Supervised Prehabilitation Exercise Program (n=16): 1. Hyponatremia: Supervised Prehabilitation Exercise Program (n=16): 1. Hypotension: Supervised Prehabilitation Exercise Program (n=16): 1. Nausea: Supervised Prehabilitation Exercise Program (n=16): 3. Platelet Count Decreased: Supervised Prehabilitation Exercise Program (n=16): 1. Sepsis: Supervised Prehabilitation Exercise Program (n=16): 1. Vertigo: Supervised Prehabilitation Exercise Program (n=16): 1.